Diagnos Laboratorium Utama PT Tbk (DGNS) — Cash Flow Quality Index
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow Quality Index of 3.53x as of June 2024. Operating cash flow of Rp3.32 Billion exceeds net income of Rp940.04 Million, indicating high earnings quality where cash backs reported profits. Also explore Diagnos Laboratorium Utama PT Tbk (DGNS) total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Diagnos Laboratorium Utama PT Tbk Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Diagnos Laboratorium Utama PT Tbk across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Diagnos Laboratorium Utama PT Tbk (DGNS) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Diagnos Laboratorium Utama PT Tbk (2017–2024)
Year-by-year earnings quality comparison for Diagnos Laboratorium Utama PT Tbk. For live market cap and the full company financial profile, see Diagnos Laboratorium Utama PT Tbk market capitalisation.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 36.52x | Rp27.30 Billion | Rp747.44 Million | ▲ +7788.8% |
| 2022 | -0.48x | Rp-6.02 Billion | Rp12.66 Billion | ▼ -151.9% |
| 2021 | 0.92x | Rp58.87 Billion | Rp64.30 Billion | ▲ +83.9% |
| 2020 | 0.50x | Rp26.23 Billion | Rp52.69 Billion | ▼ -58.8% |
| 2019 | 1.21x | Rp11.20 Billion | Rp9.27 Billion | ▲ +32.1% |
| 2018 | 0.91x | Rp8.47 Billion | Rp9.26 Billion | ▲ +277.4% |
| 2017 | -0.52x | Rp-712.00 Million | Rp1.38 Billion | — |